Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...
BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya ® (pivmecillinam) tablets, 185mg, an oral prescription antibiotic. Pivya ...
Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.
Alembic Pharmaceuticals is set to enter the high-margin US branded market with the launch of “women health antibiotic”, as it looks beyond generics to chart the next phase of growth, managing director ...
Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals (ALEM.NS), opens new tab on Thursday reported lower third‑quarter profit on Thursday after taking a one-time charge linked to India's new ...
https://www.thehindubusinessline.com/news/real-estate/google-parent-gains-exclusive-option-on-more-space-at-bengalurus-alembic-city/article70592100.ece Copy Google ...
Alembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the treatment of certain types of cancer. The tentative ...
Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution ...
Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...
Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...
Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...